A previous study by Wysocki et al. tested whether a soluble human recombinant ACE2 (rACE2) may be used to decrease ANG II and increase ANG (1–7) levels in plasma and tissues and whether rACE2 may be used to prevent ANG II-induced hypertension in mice. This evidence concerns the gene ACE2 and hypertensive disorder.